Galenica acquires Swiss company Om Pharma

Galenica acquires the entirety of Om Pharma, a fully integrated specialty biotechnology and pharmaceutical Swiss company with a unique expertise in the field of immunology. Om Pharma distributes in more than 90 countries and its products occupy a leading position in their markets.

The acquisition confirms and supports Galenica's growth strategy: Om Pharma strengthens the Vifor Pharma business sector with a successfully established product portfolio in therapeutic areas which excellently complement Vifor Pharma's existing indication areas. Om Pharma's worldwide sales force reinforces deeply Vifor Pharma's network of partners, some of whom already distribute Venofer and Maltofer. Om Pharma will be managed as a profit centre of Vifor Pharma. The acquisition will be accretive for the Galenica Group results already in 2009.

Comments

Post a Comment

Popular posts from this blog

GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut

Image
GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut    Vox Author of GOP Tax Plan Says Children's Health Insurance Program Is Held Up “Because We Don't Have Money ...    The Intercept Nevada wins short reprieve in child health care funds fight    Sacramento Bee Ben McAdams: Congress to Tiny Tim: 'No health insurance for you.'    Salt Lake Tribune Full coverage
Read more

Trump wants more mental health care; Alabama says it's trying

Image
Trump wants more mental health care; Alabama says it's trying    AL.com Budget undercuts Trump focus on mental health, school safety    Yahoo News Mental health awareness license plates offered by New York State DMV    Buffalo News Trump wants to 'tackle the difficult issue of mental health?' He should put his money where his mouth is.    Washington Post Full coverage
Read more